Europe Vital Signs Monitoring Market

Europe Vital Signs Monitoring Market Size & Growth (2022 to 2027):

As per the research report, the size of the Europe Vital Signs Monitoring market is valued at USD 1.16 billion in 2022. It is expected to grow at a CAGR of 6.5% to reach USD 1.59 billion by 2027 during the forecast period 2022 to 2027.

Increasing prevalence of chronic diseases majorly drives the vital European signs monitoring markets, high incidence of cardiovascular diseases rising demand for proactive monitoring. 

In addition, the growing geriatric population is leading the vital signs monitoring market in the region. The aging population is exposed to various chronic disorders such as diabetes and cardiovascular diseases such as hypertension. In addition, the concerns of high BP in older people require vital signs monitoring, thereby increasing the demand for these devices.

In the last decade, vital sign monitoring technologies have advanced tremendously. As a result, essential indicators are used to assess a person's overall health. Pulse rate, respiration rate, body temperature, and blood pressure are some of the measurements utilized. They aid in the early detection of chronic diseases.

However, in the recent period, the demand for personalized and home healthcare services has significantly increased, driving the market growth. In addition, technological advancements in the healthcare sector allow new market entrants to introduce innovative new devices to expand market growth. 

Further, the factors such as increasing penetration of insurance companies and collaborations between the regional companies to introduce advanced products are expanding the market growth. 

Investments and funding by the government and business organization to develop healthcare infrastructure is encouraging the market player to adopt new strategies. 

Moreover, Initiatives taken by the government for creating awareness programs about healthcare through medical tourism across the region are positively influencing the market growth. 

The region's leading market players concentrate on growing market growth through different market strategies such as collaborations, mergers, and acquisitions. Philips Healthcare is the market leader in patient monitoring equipment in Europe, including products in the areas of multi-parameter vital signs, wireless ambulatory telemetry, telehealth, fetal and neonatal monitoring, and pulse oximetry.

However, lack of awareness about the monitoring devices and stringent government policies are the major growth restraint factors for the Vital signs monitoring market. 

This research report on the Europe Vital Signs Monitoring Market has been segmented and sub-segmented into the following categories:

By Product:

• BP Monitoring Devices
• Pulse-oximeters
• Temperature Monitoring Devices

By End User:

• Hospitals
• Physician’s Office
• Home Healthcare
• Ambulatory Centres
• Emergency Care Centres
• Other Healthcare Settings

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Geographically, the Europe held the largest share of the vital signs monitoring the market, and it is anticipated to continue its growth throughout the period. The availability of advanced healthcare systems, favorable reimbursement policies, and technological advancements in the healthcare market drive the region's market growth. In addition, the developed countries in the area such as Germany, the UK, and France significantly contribute to the European regional market growth. The major companies in the region are Phillips healthcare, Medtronic, and Tunstall, which are very engaged in new product launches. 

The Germany vital signs monitoring market dominated the largest share of the vital signs monitoring the market, and it is expected to witness a prominent share during the forecast period. The high prevalence of chronic diseases, increasing preference for remote and wireless devices, and constant product innovations fuel market growth. 

Similarly, the UK vital signs monitoring market is likely to register a considerable share in the vital signs monitoring market due to increasing healthcare settings, primarily hospitals, and increasing adoption of advanced devices at hospitals and clinics. However, home healthcare services have emerged as significant end-user of these devices in recent years. Long-term care can be provided at home at a lesser rate than in hospitals. The United Kingdom has the largest market for nursing and assisted living homes.

KEY MARKET PLAYERS

Key players operating in the Europe Vital Signs Monitoring Market profiled in this report are Koninklijke Philips N.V., Medtronic, Nihon Kohden Corporation, GE Healthcare, Masimo, Omron Healthcare. Other players in the market include Contec Medical Systems Co. Ltd, A&D Company Ltd., Nonin Medical Inc., and SunTech Medical, Inc.